4,284 Shares in Teleflex Incorporated $TFX Bought by Keybank National Association OH

Keybank National Association OH purchased a new position in Teleflex Incorporated (NYSE:TFX – Free Report) during the 3rd quarter, HoldingsChannel.com reports. The fund purchased 4,284 shares of the medical technology company’s stock, valued at approximately $536,000.

Several other institutional investors and hedge funds have also added to or reduced their stakes in TFX. Kelleher Financial Advisors bought a new stake in Teleflex during the second quarter worth about $25,000. Root Financial Partners LLC purchased a new stake in shares of Teleflex in the 3rd quarter worth approximately $27,000. Next Level Wealth Planning LLC purchased a new position in Teleflex during the third quarter valued at $38,000. Heritage Family Offices LLP purchased a new stake in shares of Teleflex in the third quarter worth $39,000. Finally, Allworth Financial LP bought a new position in shares of Teleflex during the second quarter valued at $44,000. Hedge funds and other institutional investors own 95.62% of the company’s stock.

Teleflex Trading Up 1.8%

Shares of NYSE:TFX opened at $159.99 on Wednesday. Teleflex Incorporated has a 52-week low of $100.18 and a 52-week high of $161.00. The stock has a market capitalization of $6.35 billion, a price-to-earnings ratio of 19.44, a PEG ratio of 1.05 and a beta of 0.85. The company has a debt-to-equity ratio of 0.44, a quick ratio of 1.59 and a current ratio of 2.01. The stock’s 50-day simple moving average is $134.43 and its two-hundred day simple moving average is $127.90.

Teleflex (NYSE:TFX – Get Free Report) last issued its quarterly earnings data on Thursday, November 5th. The medical technology company reported $2.63 earnings per share for the quarter, topping the consensus estimate of $1.90 by $0.73. The firm had revenue of $567.80 million for the quarter, compared to analysts’ expectations of $565.52 million. Teleflex had a net margin of 13.51% and a return on equity of 10.57%. The business’s quarterly revenue was up .1% on a year-over-year basis. During the same quarter in the prior year, the business earned $3.67 EPS. Analysts expect that Teleflex Incorporated will post 7.67 EPS for the current year.

Teleflex Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Thursday, December 31st. Investors of record on Monday, November 16th will be issued a $0.34 dividend. This represents a $1.36 dividend on an annualized basis and a yield of 0.9%. The ex-dividend date of this dividend is Monday, November 16th. Teleflex’s dividend payout ratio (DPR) is currently 16.52%.

Analysts Set New Price Targets

Several brokerages have recently issued reports on TFX. Zacks Research downgraded shares of Teleflex from a “strong-buy” rating to a “hold” rating in a research note on Friday, October 23rd. Wall Street Zen upgraded Teleflex from a “hold” rating to a “buy” rating in a research note on Saturday, November 7th. Royal Bank Of Canada boosted their price target on Teleflex from $155.00 to $175.00 and gave the stock an “outperform” rating in a research note on Friday, November 6th. Truist Financial upped their price target on Teleflex from $142.00 to $167.00 and gave the company a “hold” rating in a report on Monday, November 9th. Finally, Weiss Ratings upgraded shares of Teleflex from a “sell (d)” rating to a “hold (c)” rating in a research note on Monday, November 9th. One equities research analyst has rated the stock with a Strong Buy rating, five have issued a Buy rating and six have assigned a Hold rating to the company’s stock. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $163.30.

Get Our Latest Report on Teleflex

Teleflex Profile

(Free Report)

Teleflex is a global medical technology company that develops, manufactures and markets single-use medical devices used by healthcare professionals in hospitals and other care settings. Its products support a range of procedures, including vascular access, anesthesia, critical care, surgery, urology and emergency medicine. The company’s offerings include vascular and interventional access devices, catheters, airway management products, surgical instruments and other devices used in diagnostic and therapeutic procedures.

Featured Stories

Want to see what other hedge funds are holding TFX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Teleflex Incorporated (NYSE:TFX – Free Report).

Institutional Ownership by Quarter for Teleflex (NYSE:TFX)

Receive News & Ratings for Teleflex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teleflex and related companies with MarketBeat.com's FREE daily email newsletter.